Logotype for Annovis Bio Inc

Annovis Bio (ANVS) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Annovis Bio Inc

Proxy filing summary

25 Aug, 2026

Executive summary

  • Special Meeting scheduled for October 2026 will be held virtually, allowing shareholders to vote and ask questions online using a unique control number.

  • Proxy materials are distributed primarily via the Internet to expedite delivery, reduce costs, and conserve resources, with paper copies available upon request.

  • The Board unanimously recommends voting in favor of all proposals presented at the meeting.

Voting matters and shareholder proposals

  • Proposal 1 seeks approval to amend the Certificate of Incorporation to increase authorized Common Stock from 70,000,000 to 140,000,000 and Preferred Stock from 2,000,000 to 10,000,000.

  • Proposal 2 requests ratification of an amendment to the 2019 Equity Incentive Plan, correcting a prior typographical error and increasing the share reserve to 5,500,000.

  • Proposal 3 allows adjournment of the Special Meeting if more time is needed to solicit proxies.

  • Shareholders may also transact other business as may properly come before the meeting.

  • Board recommends a vote "FOR" all proposals.

Board of directors and corporate governance

  • Directors and executive officers as a group beneficially own a small percentage of outstanding shares, with detailed ownership disclosed.

  • Board members and officers are eligible for awards under the Option Plan but receive no special benefit from the proposals beyond potential equity grants.

  • Procedures for shareholder proposals and director nominations for the 2027 Annual Meeting are outlined, including deadlines and requirements.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more